UnitedHealth Group Incorporated (NYSE:UNH) issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09, Bloomberg Earnings reports. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same quarter last year, the business posted $2.17 earnings per share. The company’s quarterly revenue was up 8.7% on a year-over-year basis. UnitedHealth Group updated its FY17 guidance to $10.00 EPS.
UnitedHealth Group (UNH) opened at 209.15 on Friday. The stock has a market capitalization of $206.85 billion, a PE ratio of 23.75 and a beta of 0.63. UnitedHealth Group has a 12-month low of $136.22 and a 12-month high of $211.70. The company’s 50-day moving average is $198.15 and its 200 day moving average is $186.99.
In other news, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. In the last 90 days, insiders sold 77,149 shares of company stock worth $15,182,242. Insiders own 0.89% of the company’s stock.
Several large investors have recently made changes to their positions in the company. Independence Trust CO purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at approximately $200,000. United Bank Inc. purchased a new position in UnitedHealth Group in the 3rd quarter valued at $201,000. Honeywell International Inc. lifted its holdings in UnitedHealth Group by 23.3% in the 3rd quarter. Honeywell International Inc. now owns 265,500 shares of the healthcare conglomerate’s stock valued at $51,998,000 after purchasing an additional 50,100 shares in the last quarter. IFC Holdings Incorporated FL lifted its holdings in UnitedHealth Group by 2.1% in the 3rd quarter. IFC Holdings Incorporated FL now owns 31,572 shares of the healthcare conglomerate’s stock valued at $6,171,000 after purchasing an additional 661 shares in the last quarter. Finally, First Business Financial Services Inc. lifted its holdings in UnitedHealth Group by 9.0% in the 3rd quarter. First Business Financial Services Inc. now owns 3,508 shares of the healthcare conglomerate’s stock valued at $687,000 after purchasing an additional 290 shares in the last quarter. Hedge funds and other institutional investors own 86.09% of the company’s stock.
A number of equities analysts have recently commented on the stock. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Citigroup Inc. lifted their price target on shares of UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a report on Wednesday, October 18th. Oppenheimer Holdings, Inc. lifted their price target on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a report on Wednesday, October 18th. Mizuho reiterated a “buy” rating on shares of UnitedHealth Group in a report on Tuesday. Finally, Cowen and Company reissued an “outperform” rating and set a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Three research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $215.27.
COPYRIGHT VIOLATION NOTICE: This piece was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2017/10/27/unitedhealth-group-incorporated-unh-posts-earnings-results-beats-expectations-by-0-09-eps.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.